Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Mixture of Adipose-derived Cells Prove Better at Inducing Bone Repair

By LabMedica International staff writers
Posted on 06 Mar 2019
Researchers have defined the differential but overlapping roles of two cell subsets involved in the paracrine induction of bone repair.

Paracrine signaling is a form of cell-to-cell communication in which a cell produces a signal to induce changes in nearby cells, altering the behavior of those cells. More...
Signaling molecules known as paracrine factors diffuse over a relatively short distance, as opposed to endocrine factors, hormones, which travel considerably longer distances via the circulatory system.

Pericytes are multi-functional cells that wrap around the endothelial cells that line the capillaries and venules throughout the body. These cells are embedded in basement membrane where they communicate with endothelial cells of the capillaries by means of both direct physical contact and paracrine signaling. Pericytes and other perivascular stem/stromal cells are of growing interest in the field of tissue engineering. A fraction of perivascular cells are well recognized to have mesenchymal stem cell (MSC) characteristics, including multipotentiality, self-renewal, immunoregulatory functions, and diverse roles in tissue repair.

Investigators at Johns Hopkins University (Baltimore, MD, USA) evaluated the differential but overlapping roles of two perivascular cell subsets in paracrine induction of bone repair. CD146+CD34−CD31−CD45−pericytes and CD34+CD146−CD31−CD45−adventitial cells were derived from human adipose (fat) tissue and applied alone or in a 1:1 combination to treat severe defects in the skulls of mice.

Results published in the January 7, 2019, online edition of the journal NPJ Regenerative Medicine revealed that pericytes induced growth of new blood vessels, while adventicytes induced the formation of bone synthesizing osteoblasts. For this study, the investigators performed in vitro osteogenic differentiation and tubulogenesis assays using either fluorescence activated cell sorting-derived CD146+ pericytes or CD34+ adventitial cells. The results indicated that the two types of cells working in tandem were better at promoting bone repair in mice than was either type by itself.

“Given these distinct but overlapping roles in bone repair, future use of a combination progenitor cell therapy may be effective,” said senior author Dr. Aaron James, associate professor of pathology at Johns Hopkins University. “Although our study used equal numbers of each type of cell, it will be important to study whether different ratios of these two cell types can support even more dramatic bone repair.”

“A prevailing theory in stem cell therapies derived from fat is that a heterogeneous cell population somehow works in concert to speed tissue regeneration, like different instruments in an orchestra playing in unison,” said Dr. James. “But the cellular or molecular mechanisms behind this theory have not been defined. The current study tried to isolate specific subpopulations of cells to try to determine which would work best. This study shows that two different cell populations - pericytes and adventicytes - can be used to regenerate tissue in a sort of beneficial duet, with distinct but complementary roles.”

Related Links:
Johns Hopkins University


Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.